174 related articles for article (PubMed ID: 11280725)
1. Adenovirus expressing RIZ1 in tumor suppressor gene therapy of microsatellite-unstable colorectal cancers.
Jiang GL; Huang S
Cancer Res; 2001 Mar; 61(5):1796-8. PubMed ID: 11280725
[TBL] [Abstract][Full Text] [Related]
2. RIZ, the retinoblastoma protein interacting zinc finger gene, is mutated in genetically unstable cancers of the pancreas, stomach, and colorectum.
Sakurada K; Furukawa T; Kato Y; Kayama T; Huang S; Horii A
Genes Chromosomes Cancer; 2001 Feb; 30(2):207-11. PubMed ID: 11135439
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein.
Harris MP; Sutjipto S; Wills KN; Hancock W; Cornell D; Johnson DE; Gregory RJ; Shepard HM; Maneval DC
Cancer Gene Ther; 1996; 3(2):121-30. PubMed ID: 8729911
[TBL] [Abstract][Full Text] [Related]
4. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T
Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054
[TBL] [Abstract][Full Text] [Related]
5. In vivo adenovirus-mediated p53 tumor suppressor gene therapy for colorectal cancer.
Spitz FR; Nguyen D; Skibber JM; Cusack J; Roth JA; Cristiano RJ
Anticancer Res; 1996; 16(6B):3415-22. PubMed ID: 9042200
[TBL] [Abstract][Full Text] [Related]
6. Frequent frameshift mutations of RIZ in sporadic gastrointestinal and endometrial carcinomas with microsatellite instability.
Piao Z; Fang W; Malkhosyan S; Kim H; Horii A; Perucho M; Huang S
Cancer Res; 2000 Sep; 60(17):4701-4. PubMed ID: 10987271
[TBL] [Abstract][Full Text] [Related]
7. The tumor suppressor activity induced by adenovirus-mediated BRCA1 overexpression is not restricted to breast cancers.
Marot D; Opolon P; Brailly-Tabard S; Elie N; Randrianarison V; Connault E; Foray N; Feunteun J; Perricaudet M
Gene Ther; 2006 Feb; 13(3):235-44. PubMed ID: 16208422
[TBL] [Abstract][Full Text] [Related]
8. RIZ1, but not the alternative RIZ2 product of the same gene, is underexpressed in breast cancer, and forced RIZ1 expression causes G2-M cell cycle arrest and/or apoptosis.
He L; Yu JX; Liu L; Buyse IM; Wang MS; Yang QC; Nakagawara A; Brodeur GM; Shi YE; Huang S
Cancer Res; 1998 Oct; 58(19):4238-44. PubMed ID: 9766644
[TBL] [Abstract][Full Text] [Related]
9. Recombinant adenovirus-p53 gene transfer and cell-specific growth suppression of human cervical cancer cells in vitro and in vivo.
Ahn WS; Bae SM; Lee KH; Lee JM; Namkoong SE; Chun HJ; Kim CK; Kim YW
Gynecol Oncol; 2004 Feb; 92(2):611-21. PubMed ID: 14766255
[TBL] [Abstract][Full Text] [Related]
10. Combination gene therapy with p53 and Thoc1/p84 is more effective than either single agent in an animal model of human pancreatic adenocarcinoma.
Yin S; Goodrich DW
Int J Oncol; 2006 Mar; 28(3):781-5. PubMed ID: 16465385
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus-mediated p53 gene therapy: overview of preclinical studies and potential clinical applications.
Horowitz J
Curr Opin Mol Ther; 1999 Aug; 1(4):500-9. PubMed ID: 11713766
[TBL] [Abstract][Full Text] [Related]
12. Effective gene-virotherapy for complete eradication of tumor mediated by the combination of hTRAIL (TNFSF10) and plasminogen k5.
Liu XY; Qiu SB; Zou WG; Pei ZF; Gu JF; Luo CX; Ruan HM; Chen Y; Qi YP; Qian C
Mol Ther; 2005 Apr; 11(4):531-41. PubMed ID: 15771956
[TBL] [Abstract][Full Text] [Related]
13. Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression.
Ji L; Fang B; Yen N; Fong K; Minna JD; Roth JA
Cancer Res; 1999 Jul; 59(14):3333-9. PubMed ID: 10416589
[TBL] [Abstract][Full Text] [Related]
14. The tumor suppressor gene RIZ in cancer gene therapy (review).
Canote R; Du Y; Carling T; Tian F; Peng Z; Huang S
Oncol Rep; 2002; 9(1):57-60. PubMed ID: 11748455
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus-p53-mediated gene therapy of anaplastic large cell lymphoma with t(2;5) in a nude mouse model.
Turturro F; Heineke HL; Drevyanko TF; Link CJ; Seth P
Gene Ther; 2000 Jun; 7(11):930-3. PubMed ID: 10849552
[TBL] [Abstract][Full Text] [Related]
16. Suppression of tumor growth using a recombinant adenoviral vector carrying the dominant-negative mutant gene Survivin-D53A in a nude mice model.
Zhu DE; Höti N; Song Z; Jin L; Wu Z; Wu Q; Wu M
Cancer Gene Ther; 2006 Aug; 13(8):762-70. PubMed ID: 16543917
[TBL] [Abstract][Full Text] [Related]
17. Complete elimination of colorectal tumor xenograft by combined manganese superoxide dismutase with tumor necrosis factor-related apoptosis-inducing ligand gene virotherapy.
Zhang Y; Gu J; Zhao L; He L; Qian W; Wang J; Wang Y; Qian Q; Qian C; Wu J; Liu XY
Cancer Res; 2006 Apr; 66(8):4291-8. PubMed ID: 16618754
[TBL] [Abstract][Full Text] [Related]
18. E2F-1 overexpression sensitizes colorectal cancer cells to camptothecin.
Dong YB; Yang HL; McMasters KM
Cancer Gene Ther; 2003 Mar; 10(3):168-78. PubMed ID: 12637937
[TBL] [Abstract][Full Text] [Related]
19. An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.
Jakubczak JL; Ryan P; Gorziglia M; Clarke L; Hawkins LK; Hay C; Huang Y; Kaloss M; Marinov A; Phipps S; Pinkstaff A; Shirley P; Skripchenko Y; Stewart D; Forry-Schaudies S; Hallenbeck PL
Cancer Res; 2003 Apr; 63(7):1490-9. PubMed ID: 12670895
[TBL] [Abstract][Full Text] [Related]
20. Tumor-specific chemo-radio-gene therapy for colorectal cancer cells using adenovirus vector expressing the cytosine deaminase gene.
Ueno M; Koyama F; Yamada Y; Fujimoto H; Takayama T; Kamada K; Naito A; Hirao S; Mukogawa T; Hamada H; Nakajima Y
Anticancer Res; 2001; 21(4A):2601-8. PubMed ID: 11724328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]